Historical salary details - Dr. Willard H. Dere, M.D., Lead Independent Director, Metagenomi Inc.
Dr. Willard H. Dere, M.D. is the Lead Independent Director of Metagenomi Inc.. They also hold 3 other positions in Biomarin Pharmaceutical Inc. - Registered Shares, Mersana Therapeutics Inc and Seres Therapeutics Inc.
Dr. Willard H. Dere, M.D.
Lead Independent Director
$ 1.4 M
Gross Remuneration
-
Current Company
Metagenomi Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Metagenomi Inc. | Lead Independent Director | 663.4 K | 1248.4 % |
| 2024 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 463.0 K | -3.6 % |
| 2024 | Mersana Therapeutics Inc | Independent Director | 161.5 K | -47.1 % |
| 2024 | Seres Therapeutics Inc | Independent Director | 116.9 K | -48.1 % |
| 2023 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 480.4 K | -1.2 % |
| 2023 | Mersana Therapeutics Inc | Independent Director | 305.4 K | 74.8 % |
| 2023 | Seres Therapeutics Inc | Independent Director | 225.2 K | - |
| 2023 | Metagenomi Inc. | Director | 49.2 K | - |
| 2022 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 486.4 K | -1.0 % |
| 2022 | Mersana Therapeutics Inc | Independent Director | 174.7 K | -42.8 % |
| 2022 | Seres Therapeutics Inc | Independent Director | - | - |
| 2021 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 491.1 K | -11.1 % |
| 2021 | Mersana Therapeutics Inc | Independent Director | 305.5 K | 57.8 % |
| 2021 | Seres Therapeutics Inc | Independent Director | - | - |
| 2020 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 552.6 K | 21.6 % |
| 2020 | Mersana Therapeutics Inc | Independent Director | 193.6 K | 57.3 % |
| 2020 | Seres Therapeutics Inc | Independent Director | - | - |
| 2019 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 454.3 K | -5.1 % |
| 2019 | Mersana Therapeutics Inc | Independent Director | 123.1 K | -52.9 % |
| 2019 | Seres Therapeutics Inc | Independent Director | 75.7 K | -43.8 % |
| 2018 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 478.7 K | 7.4 % |
| 2018 | Mersana Therapeutics Inc | Independent Director | 261.5 K | - |
| 2018 | Seres Therapeutics Inc | Independent Director | 134.7 K | -46.4 % |
| 2017 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 445.5 K | -31.3 % |
| 2017 | Seres Therapeutics Inc | Independent Director | 251.1 K | - |
| 2017 | Mersana Therapeutics Inc | Independent Director | - | - |
| 2016 | Biomarin Pharmaceutical Inc. - Registered Shares | Independent Director | 648.7 K | - |